Putting too much emphasis on dividend yield can harm the total return of your equity income investment.
Let's look at the argument that indexers fail with corporate governance.
To understand a bond portfolio's risks, look beyond volatility-based metrics.
Analysts discuss how they incorporate the moat methodology into their work.
New cancer treatments show promise for patients and investors.
Madison Mid Cap takes a moderate approach to growth.
Frank Villante of Celeste Funds Management on concentration and conviction.
|Performance Fees: An Idea Whose Time Has Come||Investment Insights||Jeffrey Ptak||08/17/2017|
|The Effect of Framing on Financial Decision-Making||Practice Builder||Michael M. Pompian||08/17/2017|
|The Perils of Funds That Narrowly Target High-Yielding Stocks||Investment Insights||Adam McCullough, CFA||08/16/2017|
|Are Index Funds Too Soft on CEOs?||Fund Times||John Rekenthaler||08/15/2017|
|Your Bond Fund Could Be Riskier Than It Looks||Investment Insights||Miriam Sjoblom||08/15/2017|
|Moats in Practice||Morningstar Conversation||Elizabeth Collins, CFA||08/14/2017|
|Opportunities in Immuno-Oncology||Sector Rap||Laura Lallos||08/14/2017|
|A Happy Medium||Undiscovered Managers||Tom Lauricella||08/14/2017|
|10 Questions with Frank Villante||10 Questions||Laura Lallos||08/14/2017|
|A Disciplined Approach to Infrastructure Investing||Fund Times||Morningstar||08/12/2017|